List of products in the National Drug Code with proprietary name . Pembrolizumab is used to treat cancer. It works by changing the action of your own immune system, directing it to attack cancer cells. Pembrolizumab belongs to a class of drugs known as monoclonal antibodies.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 83012-010 | Pembrolizumab | Liquid | Boehringer Ingelheim Fremont, Inc. | Bulk Ingredient |